false 0001595248 0001595248 2023-09-22 2023-09-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
   
 
 
FORM 8-K 
    
 
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
September 22, 2023
Date of report (Date of earliest event reported)
 
GENPREX, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
001-38244
90-0772347
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer
Identification Number)
     
3300 Bee Cave Road, #650-227, Austin, TX
 
78746
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (512) 537-7997
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.001 per share
 
GNPX
 
The Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
 
 

 
 
Item 4.01. Changes in Registrant's Certifying Accountant.
 
Engagement of New Independent Registered Public Accounting Firm
 
On September 22, 2023, Genprex, Inc. (the “Company”), upon the approval of the Audit Committee of the Company's Board of Directors, engaged WithumSmith+Brown, PC (“Withum”) as the Company’s new independent registered public accounting firm commencing with the Company’s third fiscal quarter ending September 30, 2023 and for the fiscal year ending December 31, 2023.
 
During the Company’s two most recent fiscal years ended December 31, 2021 and 2022, and the subsequent interim period through the date of Withum's engagement, neither the Company nor anyone acting on its behalf consulted with Withum regarding either of the following: (i) the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that Withum concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue, or (ii) any matter that was either the subject of a disagreement, as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions, or a “reportable event,” as described in Item 304(a)(1)(v) of Regulation S-K.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number
 
 Description
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
GENPREX, INC.
 
       
Date: September 25, 2023
By:
/s/ Ryan Confer
 
   
Ryan Confer
 
   
Chief Financial Officer
(Principal Financial Officer)
 
 
 
v3.23.3
Document And Entity Information
Sep. 22, 2023
Document Information [Line Items]  
Entity, Registrant Name GENPREX, INC.
Document, Type 8-K
Document, Period End Date Sep. 22, 2023
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-38244
Entity, Tax Identification Number 90-0772347
Entity, Address, Address Line One 3300 Bee Cave Road
Entity, Address, Address Line Two #650-227
Entity, Address, City or Town Austin
Entity, Address, State or Province TX
Entity, Address, Postal Zip Code 78746
City Area Code 512
Local Phone Number 537-7997
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol GNPX
Security Exchange Name NASDAQ
Entity, Emerging Growth Company true
Entity, Ex Transition Period true
Amendment Flag false
Entity, Central Index Key 0001595248

Genprex (NASDAQ:GNPX)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Genprex 차트를 더 보려면 여기를 클릭.
Genprex (NASDAQ:GNPX)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Genprex 차트를 더 보려면 여기를 클릭.